Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clene Inc (CLNN)

Clene Inc (CLNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clene Inc 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121 USA

https://clene.com Employees: 76 P: 801-676-9695

Sector:

Medical

Description:

Clene Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of unique therapeutics for neurodegenerative diseases. Clene Nanomedicine Inc., formerly known as Tottenham Acquisition I Limited, is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 55,474
Enterprise Value, $K 54,024
Shares Outstanding, K 11,778
Float, K 7,620
% Float 64.70%
Short Interest, K 844
Short Float 7.16%
Days to Cover 12.94
Short Volume Ratio 0.63
% of Insider Shareholders 35.30%
% of Institutional Shareholders 23.28%

Financials:

Annual Sales, $ 200 K
Annual Net Income, $ -26,170 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -9,230 K
EBIT, $ -23,080 K
EBITDA, $ -21,580 K

Growth:

1-Year Return 48.11%
3-Year Return -79.16%
5-Year Return -98.19%
5-Year Revenue Growth -4.76%
5-Year Earnings Growth 87.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.88 on 03/12/26
Next Earnings Date 05/06/26
Earnings Per Share ttm -3.01
EPS Growth vs. Prev Qtr -3.53%
EPS Growth vs. Prev Year 47.31%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/11/24

CLNN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -135.77%
Profit Margin % -13,085.00%
Debt/Equity -0.21
Price/Sales 317.42
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.62
Interest Coverage -8.76
60-Month Beta 0.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.